Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2024
Jul. 31, 2023
Current assets:    
Cash and cash equivalents $ 57,156 $ 82,373
Accounts receivable, net 3,935 4,808
Inventories, net 7,324 7,939
Prepaid expenses and other current assets, including $5,000 escrow at April 30, 2024 and $1,000 restricted cash at July 31, 2023 7,321 3,336
Total current assets 75,736 98,456
Property, plant, and equipment, net 12,638 13,086
Right-of-use assets 2,959 3,626
Other assets, including $5,000 escrow at July 31, 2023 591 5,745
Non-current assets of discontinued operations, net 1,545 967
Total assets 93,469 121,880
Current liabilities:    
Accounts payable – trade 1,520 3,575
Accrued liabilities 5,376 11,743
Current portion of operating lease liabilities 799 980
Current portion of long term debt 75 75
Convertible debentures 3,609 2,514
Current liabilities of discontinued operations, net 10,284 21,102
Total current liabilities 21,663 39,989
Operating lease liabilities, non-current 2,595 3,160
Long term debt, net 180 269
Total liabilities 24,438 43,418
Contingencies – see Note 13
Stockholders’ equity:    
Preferred Stock, $.01 par value; authorized 25,000,000 shares; no shares issued or outstanding
Common Stock, $.01 par value; authorized 75,000,000 shares; shares issued and outstanding: 51,227,535 at April 30, 2024 and 49,997,631 at July 31, 2023 511 499
Additional paid-in capital 347,069 344,435
Accumulated deficit (281,047) (268,350)
Accumulated other comprehensive income 2,498 1,878
Total stockholders’ equity 69,031 78,462
Total liabilities and stockholders’ equity $ 93,469 $ 121,880